IDO1 and acute myeloid leukemia: However, neither IDO protein levels nor IDO enzymatic activity could be evaluated in this study, thus precluding any definitive conclusion about the in vivo mechanisms than may underlie the different clinical outcome of AML patients showing high or low IDO mRNA content in BM blasts.